Monitoring chronic myeloid leukemia patients responding to treatment with tyrosine kinase inhibitors by real-time quantitative polymerase chain reaction | Zendy

AI Assistant Blog Pricing

Monitoring chronic myeloid leukemia patients responding to treatment with tyrosine kinase inhibitors by real-time quantitative polymerase chain reaction

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.